Zhefeng A. Liu
No. 37 Xueyuan Road
Haidian, 100191, China
Haidian, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
A Sandwich-Structured Piezoelectric Elastomer Containing a Porous Core Layer for Improving Output Performance.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: April 07, 2026
Analysis of survival and prognostic differences in locally advanced or metastatic non-squamous non-small cell lung cancer with KRAS mutations.
Journal: Journal of thoracic disease
Published: February 28, 2026
Expert consensus on the detection and clinical application of tumor mutational burden.
Journal: Cancer biology & medicine
Published: February 18, 2026
First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial.
Journal: Signal transduction and targeted therapy
Published: June 06, 2025
Safety and efficacy of Cisplatin in combination with Sintilimab and Niraparib in patients with advanced solid tumors: A phase Ib study.
Journal: Cancer pathogenesis and therapy
Published: May 08, 2025
A Real-Time Solar UVA Dose Monitor Based on Recyclable Azobenzene-Containing Elastomer Fabrics.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 24, 2025
International guidelines on the diagnosis and treatment of NUT carcinoma.
Journal: Innovation (Cambridge (Mass.))
Published: April 11, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.
Journal: Cancer biology & medicine
Published: April 09, 2025
Expert consensus on cancer treatment-related lung injury.
Journal: Journal of thoracic disease
Published: February 12, 2025
Mechanism of action and future perspectives of ADCs in combination with immune checkpoint inhibitors for solid tumors.
Journal: Clinical and experimental medicine
Published: February 12, 2025
Comparative outcomes of first-line PD-1/PD-L1 inhibitors plus chemotherapy for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis of randomized clinical trials.
Journal: Translational lung cancer research
Published: January 22, 2025
Clinical characteristics and survival outcomes of long-term responders for advanced nonsmall cell lung cancer patients with first-line PD-1/PD-L1 inhibitors: a multicenter retrospective study.
Journal: Postgraduate medical journal
Published: December 30, 2024
Last Updated: 09/26/2026